What does CUSIP 04280A100 represent in this 13F holders report?

CUSIP 04280A100 is the security identifier for ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in Q2 2020?

238 institutional investors reported ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 135,488,140
Total 13F shares: 68,613,840
Share change: +2,443,918
Total reported value: $2,962,938,209
Put/Call ratio: 66%
Price per share: $43.19
Number of holders: 238
Value change: +$129,556,464
Number of buys: 126
Number of sells: 100

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 04280A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.2%	12,431,618	$357,658,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	7.1%	9,628,526	$277,013,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	3.2%	4,294,674	$123,558,000	—	31 Mar 2020	13F
Johnson & Johnson Innovation - JJDC, Inc.	13F	Company	2.4%	3,260,869	$93,815,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	2.3%	3,170,140	$91,204,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	2.1%	2,829,880	$81,416,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	1.2%	1,619,185	$46,584,000	—	31 Mar 2020	13F
FIRST MANHATTAN CO. LLC.	13F	Company	1.2%	1,616,023	$46,492,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,515,643	$43,605,000	—	31 Mar 2020	13F
Fiera Capital Corp	13F	Company	0.98%	1,331,527	$38,308,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.79%	1,065,597	$30,658,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.77%	1,044,194	$30,041,000	—	31 Mar 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.74%	1,000,000	$28,770,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.6%	810,892	$23,330,000	—	31 Mar 2020	13F
Vivo Capital, LLC	13F	Company	0.57%	768,674	$22,115,000	—	31 Mar 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.52%	707,867	$20,365,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.52%	703,026	$20,227,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.51%	685,397	$19,719,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.5%	676,121	$19,452,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.49%	666,400	$19,172,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.46%	625,500	$17,996,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.21%	282,508	$17,517,000	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	0.44%	600,000	$17,262,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.42%	572,403	$16,468,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.4%	535,766	$15,414,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.38%	514,816	$14,811,000	—	31 Mar 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.38%	513,553	$13,619,426	—	31 Mar 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.35%	472,933	$13,606,000	—	31 Mar 2020	13F
Financial Gravity Asset Management, Inc.	13F	Company	— class O/S missing	462	$13,299,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.33%	451,010	$12,976,000	—	31 Mar 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.32%	438,025	$12,602,000	—	31 Mar 2020	13F
Aquilo Capital Management, LLC	13F	Company	0.32%	436,514	$12,559,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.31%	419,953	$12,083,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	413,937	$11,909,000	—	31 Mar 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.28%	382,870	$11,015,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.27%	360,622	$10,375,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.25%	345,165	$9,930,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.24%	323,310	$9,302,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.23%	311,331	$8,957,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.19%	252,853	$7,275,000	—	31 Mar 2020	13F
CWM, LLC	13F	Company	0.06%	82,196	$6,807,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.17%	226,937	$6,529,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.16%	214,681	$6,176,000	—	31 Mar 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.15%	203,513	$5,855,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.14%	194,708	$5,602,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.14%	194,450	$5,594,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.14%	185,948	$5,351,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.12%	167,100	$4,807,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.11%	154,600	$4,448,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.11%	152,160	$4,378,000	—	31 Mar 2020	13F

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q2 2020

As of 30 Jun 2020, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 238 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,613,840 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., Johnson & Johnson Innovation - JJDC, Inc., FMR LLC, NORTHERN TRUST CORP, FIRST MANHATTAN CO, GEODE CAPITAL MANAGEMENT, LLC, and CREDIT SUISSE AG/. This page lists 238 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

228

Q2 2020 holders

238

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.